We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 24,942 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/4/2017 21:57 | I second that Parob, Per said the same to me.IMO its hard not to be impressed by SoH, The guy is as sharp as a tac, knows the science inside out and has an incredible business brain. I've met dozens of CEO's over the years but SoH really stands out, which is why i trust him with a significant portion of my wealth | trotterstrading | |
25/4/2017 21:55 | Re 22695 from deep p, on the free shares, he reckons NOT retrospective , so by that token he will just announce on the day, sometime very soon and you will have to then hold the shares until a future date, in order to qualify , I don't know if that is right. If so, then anyone not holding , should perhaps buy and hope in anticipation of benefitting. | lukead | |
25/4/2017 21:36 | A great overview there Deeppockets. Just to add SOH said the other divisions could be floated this or next year.I spoke at length to both Per and Christina, who are both very excited about this space and their roles. One of the main pull factors was SOH. Both very complimentary about him. Further news on skin shares in the spring/by summer at the latest, all being well. | parob | |
25/4/2017 21:25 | Skin announcement in the spring, it will happen as soon as they get approval on distribution method (i.e. regulatory, tax and legal), so, it could be a few weeks or longer, but should be complete before summer | trotterstrading | |
25/4/2017 21:19 | Did Stephen Ohara confirm there will be an announcement on skin shares in the next few weeks or are you assuming this will happen? You should make it clear what he says vs. your opinion. | branboyd1 | |
25/4/2017 21:15 | OverallSOH was really excited about the future as ever, but also frustrated about market reaction to good announcements. He showed a slide showing Probi MCap compared to sales etc and was saying how some divisions could easily be worth £60+m each. He also mentioned when he was looking at other areas he was looking at Cognitive Health - stress, anxiety, autism, Alzheimer's and hinted that he was looking at those areas and might look to acquire IP in those areas which he could do the same as SKIN i.e x10 value in a year. He mentioned tests in autism particularly that excited him. He was very positive about the new team, esp Per and Christina. | deeppockets | |
25/4/2017 21:09 | SkinHe said they are keen to get products out early and can be across a range of areas, skin tightening (anti ageing), wound management, eczema, MRSA etc. They want to release value to OPTI shareholders and talking to advisors and lawyers to find best way of doing that without reducing value. When it is announced ( in next few weeks hopefully) shareholders in OPTI on that day will benefit, so not retrospective but there will be probably be a lock-in or phased release to stop people selling quickly and damaging SP? | deeppockets | |
25/4/2017 21:09 | Deep pockets that last post has some great information. I'm very pleased that someone made it there . Thanks | bobdown2 | |
25/4/2017 21:06 | again thanks DP, should be further RNS'S soon to add a few more pence and keep the TA in the right direction. | lukead | |
25/4/2017 21:05 | SugarsSOH was very excited by this area. They are the only company globally who can modulate the microbiome. He thinks people still don't yet realise the value here. They are hoping for products later this year because the market needs healthy sugars because of sugar tax etc so getting products to market will get corporates looking. They are doing more human studies in June/July but could do deals with current products. He thinks this division could be worth more than all the others put together.. | deeppockets | |
25/4/2017 21:02 | Thanks deeppockets for your initial report. | rafboy | |
25/4/2017 21:01 | From the presentation:Optiscr | deeppockets | |
25/4/2017 20:11 | P.s. I'll probably get a thumbs down now... Ha ha | joyjoy13 | |
25/4/2017 20:08 | Thanks Deeppockets, Appreciate feedback. With regards someone giving the thumbs down vote, I've noticed that for ages, wouldn't take any notice. It goes in waves, every comment for a few hours gets the same... Someone needs to get outdoors more.... Just my thoughts. But must be horrible to be so negative all the time. If who ever is posting the thumbs down all the time, hey, if you don't like OPTI then sell up and move on... | joyjoy13 | |
25/4/2017 20:06 | More to come when I get home! Connection problems! | deeppockets | |
25/4/2017 20:03 | Thanks deeppockets. I was hoping for more especially on on the sbtx shares. | incanus | |
25/4/2017 19:53 | The ascending channel firmed up today with further contact - the fourth - with the lower trendline...and a nice long shadow on the candlestick. M | marnewton | |
25/4/2017 19:48 | Well here goes and forgive me if I ramble from my notes:As ever SOH was very upbeat about the future and stressed we are now moving from an R&D company to commercialisation.Hi | deeppockets | |
25/4/2017 19:24 | Some are made to be a company shareholder's delight, being so pleased with everything and that is fine and dandy, possibly won't be so pleased if, this time next year, the share price remains stagnant. Still, we are all hoping it will be well over £1 by then. PS, I can see where SOH is coming from, by not letting traders have their way , re the skin shares/OPTI, but it is a little bit like being held to ransom, with these 2 dates when you appear to have been an OPTI shareholder in order to qualify for free shares. PS hey cowardly someone, give us a chance, i only just posted and you give me a thumbs down, whoever you are, i take my hat off to you, as you are just so quick off the mark, you must have your eyes peeled to the OPTI screen, 24 hours, looking out for 'lucked'......LOL PS 2 now, lets see who is a premium member and therefore can vote Dow, well bob's a contender...... | lukead | |
25/4/2017 19:10 | Diamond Fibre I don't think he'd sell either, think he's too passionate about OPTI but...hey...couple of years down the line and the price is right, who knows. Elrico I like the sound of them too, family company...hopefully means all pulling together for the same cause. Like the word "enlightenment"! Well, no news yet from the attendees... Hopefully after their evening meals they'll post something... Hey, perhaps they've all stayed behind and gone for a pint for a face to face chin wag... I'm not sure what I'm really expecting them to report back to be honest, very in depth RNS this morning and then the nice surprise few hours later.. Anyhow, delighted with progress so far, couldn't ask for more and we've the May event to look forward to. All good stuff.. | joyjoy13 | |
25/4/2017 18:37 | HLH BioPharma The company HLH BioPharma Vertriebs GmbH from Balve / Sauerland is an innovative family company. The company HLH BioPharma Vertriebs GmbH was founded 1994 in Balve / Sauerland. For more than 10 years, we have been dealing with the topic of probiotic therapy concepts. Today, HLH is one of the leading German providers of probiotic food supplements. The Lactobact® product series is a solid naturopathic therapeutic device for many physicians and medical practitioners. In addition to the probiotic preparations, orthomolecular products and enzyme preparations represent an essential component of the product range. Our aim is to constantly supplement the portfolio with further high-quality products. Enlightenment is one of the top principles of our entrepreneurial activity. Www.hlh-biopharma.de | elrico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions